Regeneus’ Progenza stem cell therapy clears initial safety review – Proactive Investors Australia
Proactive Investors Australia |
Regeneus’ Progenza stem cell therapy clears initial safety review
Proactive Investors Australia Regeneus’ (ASX:RGS) off-the-shelf allogeneic stem cell treatment for knee osteoarthritis, Progenza, has enhanced its potential for commercialisation for the company after an encouraging review of safety data from an oversight committee in early trialling. |
Arizona Daily Sun |
Program pays up to $800 for blood stem cells donations, but donors are hard to …
Arizona Daily Sun Blood stem cells, identified in the early 1960s, were the first type of stem cells discovered and launched a new era of research. Like other stem cells, they can copy themselves, differentiate into specialized cells and undergo cell death — functions … |
|
Fetal liver hematopoietic stem cell niches associate with portal vessels
Science Magazine (subscription) Hematopoietic stem cells (HSCs) undergo dramatic expansion in the fetal liver before migrating to their definitive site in the bone marrow. Khan et al. identify portal vessel–associated Nestin+NG2+ pericytes as critical HSC niche components (see the … |
UPI.com |
3D “Squeeze” Helps Adult Cells Become Stem Cells
Genetic Engineering & Biotechnology News (press release) A convergence of physical and chemical factors can turn adult cells into stem cells more efficiently than chemical factors alone. The physical factors that can help induce pluripotency amount to a kind of cellular swaddling, the formation of a three … Scientists pressure cells into becoming stem cellsUPI.com Squeezing cells into stem cellsPhys.Org Swiss scientists find novel way to make stem cellsswissinfo.ch |